View More Recent Stories

Oct 29, 2024 01:45PM BofA Securities Upgrades Incyte (INCY) to Buy
Oct 29, 2024 07:03AM Incyte (INCY) Tops Q3 EPS by 4c
Oct 22, 2024 12:31PM Oppenheimer Reiterates Outperform Rating on Incyte (INCY)
Oct 1, 2024 06:14AM Wolfe Research Starts Incyte (INCY) at Outperform
Sep 19, 2024 06:36AM Incyte (INCY) PT Raised to $61 at Deutsche Bank
Sep 18, 2024 05:17PM Syndax (SNDX) and Incyte (INCY) Announce New England Journal of Medicine Publication of Data from Pivotal AGAVE-201 Trial of Niktimvo
Sep 18, 2024 06:01AM Truist Securities Downgrades Incyte (INCY) to Hold
Sep 16, 2024 08:54AM TD Cowen Reiterates Buy Rating on Incyte (INCY)
Sep 16, 2024 06:29AM Incyte (INCY) PT Raised to $68 at BofA Securities
Sep 16, 2024 05:05AM Goldman Sachs Reiterates Neutral Rating on Incyte (INCY)
Sep 9, 2024 08:44AM TD Cowen Reiterates Buy Rating on Incyte (INCY)
Aug 19, 2024 05:58AM JMP Securities Reiterates Market Perform Rating on Incyte (INCY)
Aug 15, 2024 04:30PM Incyte (INCY) Announces Positive Topline Results from Pivotal Study of Tafasitamab in R/R Follicular Lymphoma
Aug 15, 2024 09:27AM Syndax Pharmaceuticals (SNDX) PT Raised to $34 at Citi
Aug 15, 2024 08:57AM BMO Capital Reiterates Underperform Rating on Incyte (INCY)
Aug 15, 2024 06:14AM Incyte (INCY) PT Raised to $67 at RBC Capital
Aug 14, 2024 03:12PM FDA Approves Incyte's (INCY) Niktimvo for cGVHD
Jul 31, 2024 06:22AM Incyte (INCY) PT Raised to $66 at RBC Capital
Jul 30, 2024 07:03AM Incyte (INCY) Misses Q2 EPS by 269c; raises guidance
Jul 26, 2024 05:33AM Incyte (INCY) PT Lowered to $81 at Oppenheimer
Jul 2, 2024 04:15AM BMO Capital Downgrades Incyte (INCY) to Underperform
Jun 13, 2024 08:07AM Incyte (INCY) Announces Final Results of Tender Offer
Jun 11, 2024 08:01AM Incyte (INCY) Announces Preliminary Results of Tender Offer
Jun 11, 2024 05:21AM Increasing unusual option volume: SANA FFIE INCY MBLY CRDO OPRA EFA DM IMVT
Mar 22, 2024 08:00PM 4 Buy-rated Healthcare stocks with 30-45% upside
View More Recent Stories